Valvular heart disease is rare in Parkinson's disease patients treated with pergolide

被引：0
|
作者：
Ruzicka, E.
Linkova, H.
Penicka, M.
Roth, J.
Ulmanova, O.
Novakova, L.
Havlikova, M.
机构：
[1] Charles Univ, Dept Neurol, Prague, Czech Republic
[2] Charles Univ, Dept Cardiol, Prague, Czech Republic
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [31] Frequency of restrictive valvular heart disease in patients with Parkinson's disease treated with pergolide, an ergot-derived anti-parkinsonian drug: a case-control echocardiographic study
    Schlesinger, I
    Katz, M
    Aharon-Perez, J
    Badarny, S
    Bloch, I
    Gross, B
    Agmon, Y
    JOURNAL OF NEUROLOGY, 2005, 252 : 30 - 30
  • [32] Pergolide-induced lung disease in patients with Parkinson's disease
    Kastelik, JA
    Aziz, I
    Greenstone, MA
    Thompson, R
    Morice, AH
    RESPIRATORY MEDICINE, 2002, 96 (07) : 548 - 550
  • [33] Valvular heart disease in Parkinson's Disease patients treated with dopamine agonists: A reader-blinded monocenter echocardiography
    Junghanns, S
    Fuhrmann, J
    Simonis, G
    Oehlwein, C
    Koch, R
    Strasser, RH
    Reichmann, H
    Storch, A
    NEUROLOGY, 2006, 66 (05) : A48 - A48
  • [34] Dopamine agonists and valvular heart disease in patients with Parkinson's disease: evidence and mystery
    Yamamoto, Mitsutoshi
    Uesugi, Tadahisa
    JOURNAL OF NEUROLOGY, 2007, 254 (Suppl 5) : 74 - 78
  • [35] Assessment of valvular heart disease in patients with Parkinson's disease on ergot dopamine agonists
    Kenangil, G.
    Ozekmekci, S.
    Koldas, L.
    Sahin, T.
    Erginoz, E.
    MOVEMENT DISORDERS, 2006, 21 : S610 - S611
  • [36] Dopamine agonists and valvular heart disease in patients with Parkinson's disease: evidence and mystery
    Mitsutoshi Yamamoto
    Tadahisa Uesugi
    Journal of Neurology, 2007, 254 : 74 - 78
  • [37] Pergolide-associated valvular heart disease in Singapore
    Reactions Weekly, 2005, 1038 (1) : 4 - 4
  • [38] Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation
    Krishnaswami, Ashok
    Albers, Kathleen B.
    Fross, Robin D.
    Jang, James J.
    Berkheimer, Sarah B.
    Ben, Valerie C. Kwai
    VanDenEeden, Stephen K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (03) : 276 - 280
  • [39] The pharmacokinetics of pergolide in Parkinson's disease
    Blin, O
    CURRENT OPINION IN NEUROLOGY, 2003, 16 : S9 - S12
  • [40] Plasma homocysteine levels in pergolide-treated Parkinson disease patients
    Özkan, S
    Colak, Ö
    Kutlu, C
    Ertan, M
    Alatas, Ö
    CLINICAL NEUROPHARMACOLOGY, 2004, 27 (04) : 163 - 165
12345